
Chemistry and biodiversity (2019)
Update date:2022-08-04
Topics:
Cao, Xudong
Yao, Zhongyuan
Dou, Fei
Zhang, Yifang
Qiu, Yinli
Zhao, Song
Xu, Xiangqing
Liu, Xin
Liu, Bi-Feng
Chen, Yin
Zhang, Guisen
In this study, a series of phenyl-1,2,4-oxadiazole derivatives were synthesized and evaluated for anti-allodynic activity. Structure–activity relationship studies identified 1-{4-[3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl]butyl}piperidine (39) with excellent affinity for the σ1 receptor and selectivity for the σ2 receptor, with poor activity to other central nervous system neurotransmitter receptors and transporters associated with pain. Compound 39 exhibited dose-dependent efficacy in suppressing the formalin-induced flinching and attenuating mechanical allodynia in chronic constriction injury-induced neuropathic rats. These results suggest that compound 39 exerts potent antihyperalgesic activity and could be considered as a promising candidate for treating neuropathic pain.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Huixian Tiankai Paper Making Agent CO.,Ltd.
Contact:+86-373-6899808
Address:Mengdian Industrial Avenue,Huixian,Xinxiang,Henan,China
Shanghai PuYi Chem-Tech Co.,Ltd.
Contact:+86-21-57687505-227
Address:3 Floor, Building 11, No 201 MinYi Road, Songjiang District, Shanghai 201612, China
SHAANXI FUJIE PHARMACEUTICAL CO.,LTD
website:http://www.fujiepharm.com
Contact:+86-29-63650906
Address:Yuanqu Yi Road, Qinghe Food Industrial Park, Sanyuan County, Shaanxi Province, China
Doi:10.1002/anie.200702563
(2007)Doi:10.1021/ja00870a038
(1962)Doi:10.1021/ja068513e
(2007)Doi:10.1016/j.bmcl.2007.07.048
(2007)Doi:10.3762/bjoc.11.148
(2015)Doi:10.1016/j.bmcl.2012.01.077
(2012)